NEW YORK, July 22, 2004 (GenomeWeb News) - Sequenom and the National Human Genome Research Institute announced today that they will perform allele-specific gene expression of genes that confer susceptibility to type 2 diabetes, building upon a previous research collaboration between the partners.


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.